CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M. Bange, John P. Reilly, Nicholas Han et al.|Nature Medicine|2021Cited by 519
Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trialAngela DeMichele, Lewis A. Chodosh, Christopher J. Sterner et al.|Nature Medicine|2025Cited by 24